VYVGART Hytrulo prefilled syringe for self-injection (single-dose subcutaneous injection: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase) has been approved by the U.S. FDA for the treatment of adults with anti-AChR antibody-positive generalized myasthenia gravis (gMG). The VYVGART Hytrulo prefilled syringe is a self-injection that takes about 20-30 seconds.* It is injected under the skin (subcutaneously). Patients and/or their caregivers will receive in-person… Read more »
Partners and Friends of Conquer MG
